Metastatic Squamous Neck Cancer With Occult Primary  >>  Halaven (eribulin mesylate)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Halaven (eribulin mesylate) / Eisai
NCT00337129: S0618 E7389 in Treating Patients With Metastatic or Recurrent Head and Neck Cancer

Completed
2
42
US
eribulin mesylate, E7389
National Cancer Institute (NCI)
Head and Neck Cancer
08/08
07/11

Download Options